-Search query
-Search result
Showing all 45 items for (author: agostino & e)
EMDB-18659:
Cryo-EM Structure of Human Kv3.1 in Complex with Modulator AUT1
Method: single particle / : Chi G, Mckinley G, Marsden B, Pike ACW, Ye M, Brooke LM, Bakshi S, Pilati N, Marasco A, Gunthorpe M, Alvaro G, Large C, Lakshminaraya B, Williams E, Sauer DB
EMDB-18660:
Cryo-EM Structure of Human Kv3.1 in Complex with Modulator AUT5
Method: single particle / : Chi G, Mckinley G, Marsden B, Pike ACW, Ye M, Brooke LM, Bakshi S, Lakshminarayana B, Pilati N, Marasco A, Gunthorpe M, Alvaro GS, Large CH, Williams E, Sauer DB
PDB-8quc:
Cryo-EM Structure of Human Kv3.1 in Complex with Modulator AUT1
Method: single particle / : Chi G, Mckinley G, Marsden B, Pike ACW, Ye M, Brooke LM, Bakshi S, Pilati N, Marasco A, Gunthorpe M, Alvaro G, Large C, Lakshminaraya B, Williams E, Sauer DB
PDB-8qud:
Cryo-EM Structure of Human Kv3.1 in Complex with Modulator AUT5
Method: single particle / : Chi G, Mckinley G, Marsden B, Pike ACW, Ye M, Brooke LM, Bakshi S, Lakshminarayana B, Pilati N, Marasco A, Gunthorpe M, Alvaro GS, Large CH, Williams E, Sauer DB
EMDB-15763:
Untreatment WT HIV-1 immature gag
Method: subtomogram averaging / : Waheed AA, Zhu Y, Agostino E, Naing L, Soheilian F, Song Y, Zhang P, Yoo S, Shlusher SB, Haughey N, Freed OE
EMDB-15764:
PDDC treatment HIV immature Gag
Method: subtomogram averaging / : Waheed AA, Zhu Y, Agostino E, Naing L, Soheilian F, Song Y, Zhang P, Yoo S, Shlusher SB, Haughey N, Freed OE
EMDB-24533:
SARS-CoV-2 spike protein bound to the S2P6 and S2M11 Fab fragments
Method: single particle / : Sauer MM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-23577:
SARS-CoV-2 S/S2M11/S2X333 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23578:
SARS-CoV-2 S/S2M11/S2L28 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23579:
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23580:
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23581:
SARS-CoV-2 S/S2M11/S2M28 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23582:
SARS-CoV-2 S/S2M11/S2M28 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-23583:
SARS-CoV-2 S/S2M11/S2M24 map
Method: single particle / : McCallum M, Veesler D
EMDB-23584:
SARS-CoV-2 S/S2X28 map
Method: single particle / : McCallum M, Veesler D
EMDB-23585:
SARS-CoV-2 S/S2M11/S2X316 map
Method: single particle / : McCallum M, Veesler D
EMDB-23586:
SARS-CoV-2 S/S2M11/S2L20 map
Method: single particle / : McCallum M, Veesler D
PDB-7lxw:
SARS-CoV-2 S/S2M11/S2X333 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7lxx:
SARS-CoV-2 S/S2M11/S2L28 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7lxy:
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7lxz:
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ly0:
SARS-CoV-2 S/S2M11/S2M28 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ly2:
SARS-CoV-2 S/S2M11/S2M28 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22491:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22492:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22494:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22497:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22506:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22507:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22508:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22512:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22516:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22517:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv2:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv4:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv6:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jva:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jvc:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jw0:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22659:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22660:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22668:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k43:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k45:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k4n:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)